Professor of Medicine, Director, Early Drug Development Program Yale University Cancer Center

Oncology

Joseph Eder is an expert in the field of Oncology. He went to Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49/84 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Joseph P. Eder is a published MD. He has 25 papers published. The most current publication "MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer." He accepts Medicare.

Publications

---

• MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder Cancer.
• New strategies in personalized medicine for solid Tumors: molecular markers and clinical trial designs.
• A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas.
• Phase I Studies of CBP501, a G2 Checkpoint Abrogator, as Monotherapy and in Combination with Cisplatin in Patients with Advanced Solid Tumors.
• A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2.
• Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor...
• Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-sma...
• A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid Tumors.
• Novel therapeutic inhibitors of the c-Met signaling pathway in Cancer.
• Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid Tumors.
• Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid Tumors.
• A Phase I study of bortezomib plus irinotecan in patients with advanced solid Tumors.
• Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid Tumors.
• A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid Tumors.
• Phase I and pharmacokinetic study of the dolastatin-15 Analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanc...
• Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory...
• Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid Tumors.
• Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung Cancer.
• A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with proTracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies.
• Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid Tumors.
• Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells.
• Phase I clinical trial and pharmacokinetic study of the spicamycin Analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients w...
• Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.
• A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid Tumors.

Schools

---

• Georgetown University School Of Medicine

• Georgetown University

• Beth Israel Hospital

• Dana Farber Cancer Institute

Conditions Treated

---

• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• Bile Duct Cancer
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Education

---

• Beth Israel Deaconess Medical Center
• Georgetown University Hospital
• Georgetown University School of Medicine

Hospital

---

• Yale-New Haven Hospital
• Massachusetts General Hospital
• Brigham and Women's Hospital

Drug Facts

---

NPI NUMBER		1043233497
NPPES Provider LastName		EDER
NPPES Provider FirstName		JOSEPH
NPPES Provider ZIPCode		022155400
NPPES Provider State		MA
Specialty Description		Medical Oncology
Total Claim Count		36.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1043233497
Last Name Of The Provider	EDER
First Name Of The Provider	JOSEPH
View All

Similar Doctors

---

	Harshabad Singh, MB BS This Doctor is OpenDoctor Recommended.
	Dr. Marcus O. Butler, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew J. Aguirre, MD This Doctor is OpenDoctor Recommended.
	Dr. Eunice L. Kwak, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Gerburg M. Wulf, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Adam B. Lerner, MD This Doctor is OpenDoctor Recommended.
	Dr. Marios Giannakis, MD This Doctor is OpenDoctor Recommended.
	Dr. Wendy S. Garrett, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Benjamin L. Ebert, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kerry L. Massman, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeffrey M. Peppercorn, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Edwin Choy, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Rizwan Haq, MD This Doctor is OpenDoctor Recommended.
	Dr. Nageatte Ibrahim, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles S. Fuchs, MD
	Dr. Karen H. Antman, MD This Doctor is OpenDoctor Recommended.
	Dr. Raymond L. Comenzo, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Amy E. Fallon, MD This Doctor is OpenDoctor Recommended.
	Dr. John M. Sloan, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog